Medicare Enrolled

Dr. Najib Saba, MD

Radiation Oncology · Ft Lauderdale, FL
Practice pattern: Cardiac Imaging — Practice with significant diagnostic imaging and stress testing
5000 W OAKLAND PARK BLVD, Ft Lauderdale, FL 33313
9547356000
Registered in NPPES since 2006
NPI: 1710966791 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Saba from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Saba? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Saba

Dr. Najib Saba is a radiation oncology specialist in Ft Lauderdale, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Saba performed 1,486 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Saba received a total of $535 from 6 pharmaceutical and/or device companies across 6 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Saba is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 1,486 Medicare services $535 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,486
Medicare services
Bottom 26% in FL for radiation oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$563
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
485 $735 $5,079
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 315 $332 $432
Gallium Ga-68 gozetotide diagnostic injection
A diagnostic injection of the radiopharmaceutical Gallium Ga-68 gozetotide (brand name Illuccix) used for imaging purposes.
193 $797 $1,016
Piflufolastat F-18 diagnostic injection
A diagnostic injection of the radioactive tracer piflufolastat F-18 used for imaging. The dose specified is 1 millicurie.
108 $473 $604
Whole body nuclear medicine scan with CT
A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body.
96 $976 $6,467
Technetium Tc-99m medronate diagnostic injection
An injection of Technetium Tc-99m medronate used for diagnostic imaging studies. The dose administered is up to 30 millicuries per study.
43 $30 $54
Whole body bone and joint nuclear medicine scan
A nuclear medicine imaging test that uses a radioactive tracer to create pictures of the entire skeleton and joints. This scan helps evaluate bone health and detect abnormalities throughout the body.
41 $153 $655
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
31 $60 $1,183
Nuclear medicine parathyroid study
A nuclear medicine imaging test used to evaluate the parathyroid glands.
29 $30 $563
Brain nuclear medicine study with metabolic evaluation
A nuclear medicine imaging test that uses radioactive tracers to evaluate brain metabolism. This procedure helps assess how brain tissues are functioning at a metabolic level.
19 $1,179 $5,500
SPECT nuclear medicine scan, 1 area
A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body.
18 $270 $855
Nuclear medicine lung circulation study
A nuclear medicine test that uses a small amount of radioactive material to create images of blood flow through the lungs.
16 $28 $477
Nuclear medicine stomach emptying study
A nuclear medicine test used to assess how quickly the stomach empties its contents.
15 $193 $686
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries 14 $7 $85
Nuclear medicine liver and bile duct study with drugs
A nuclear medicine imaging test to examine the liver and bile duct system using administered drugs.
13 $291 $854
Technetium Tc-99m sulfur colloid diagnostic injection
A diagnostic injection of Technetium Tc-99m sulfur colloid used for imaging studies. The dose administered is up to 20 millicuries per study.
13 $56 $100
I-123 ioflupane diagnostic injection
A diagnostic injection of I-123 ioflupane used for imaging studies, with a dose up to 5 millicuries.
13 $2,136 $2,750
Bone scan with multiple time points
A nuclear medicine imaging test that captures images of the bones at various intervals to assess bone health and detect abnormalities.
12 $245 $775
Injection, sincalide, 5 micrograms 12 $98 $190
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$535
Total received (2023-2024)
Avg $268/year across 2 years
Top 32% in FL for radiation oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
6
Companies
6
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$410
2023
$125

Payments by company (2024)

PROGENICS PHARMACEUTICALS, INC.
$122
HEARTFLOW, INC.
$116
GE HEALTHCARE
$78
Eisai Inc.
$59
MIM Software Inc.
$35
Top 3 companies account for 77.0% of 2024 payments
All-time payments by company (2023-2024) ›
Blue Earth Diagnostics Limited
$125
PROGENICS PHARMACEUTICALS, INC.
$122
HEARTFLOW, INC.
$116
GE HEALTHCARE
$78
Eisai Inc.
$59
MIM Software Inc.
$35
Top 3 companies account for 67.8% of all-time payments
Associated products mentioned in payments ›
ENCORE · FFRct · Leqembi · POSLUMA · PYLARIFY
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a radiation oncology specialist in Ft Lauderdale?
Compare radiation oncologists in the Ft Lauderdale area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists in nearby ZIP areas
347
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA MERCY HOSPITAL
2.7 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Saba is a cardiac imaging specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Saba experienced with nuclear medicine scan from skull base to mid-thigh with ct?
Based on Medicare claims data, Dr. Saba performed 485 nuclear medicine scan from skull base to mid-thigh with ct services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Saba receive payments from pharmaceutical companies?
Yes. Dr. Saba received a total of $535 from 6 companies across 6 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Saba's costs compare to other radiation oncologists in Ft Lauderdale?
Dr. Saba's average Medicare payment per service is $563. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Saba) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →